DTaP vaccine trial for healthy infants aged 2 months
Part of Immune system & allergy, Infections clinical trials.
This trial tests a new vaccine that protects against diphtheria, tetanus, and pertussis (whooping cough). It is for healthy infants who are about 2 months old and live permanently in the area. The goal is to see if the vaccine is safe and works well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be between 60 and 89 days old (about 2 months old) at the start.
- Your baby should be generally healthy, with no serious medical conditions.
- Your baby cannot have already received certain vaccines like DTaP, polio, or Hib.
- Your baby must not have had whooping cough, diphtheria, or tetanus before.
- Your baby cannot be born before 37 weeks, have low birth weight (under 2.5 kg/5.5 lbs), or have had birth complications.
- You must be able to provide valid ID for your baby and yourself, and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combined vaccine for diphtheria, tetanus, and whooping cough (pertussis) in children of different ages. It aims to see if the vaccine is safe and how well it works, helping to protect against these serious diseases.
This trial tests a new combined vaccine that protects against whooping cough, diphtheria, and tetanus for people aged 10 and older. It aims to see if the vaccine is safe and how well it works to boost immunity in teens and adults.
This study tests a new type of whooping cough vaccine given to pregnant women to see if it helps protect their babies from whooping cough in the first months of life. The vaccine is given during pregnancy, and then the baby's immune response is checked up to 15–18 months old.
This trial tests a new combination vaccine that protects infants against diphtheria, tetanus, and whooping cough. It is for healthy 3-month-old babies whose parents have not yet given them a similar shot.
This trial tests a new combination vaccine that protects against whooping cough, Haemophilus influenzae type b (a cause of meningitis and pneumonia), and several types of meningococcal disease (a cause of meningitis and bloodstream infections). It may help reduce the number of shots needed for children.
This study tests a lower-dose vaccine that protects against diphtheria, tetanus, and whooping cough. It aims to see if the vaccine is safe and how well it works for people aged 6 and older, possibly offering a booster with fewer side effects.
Hear when a new Prevent Whooping Cough trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.